---
document_datetime: 2023-09-21 17:04:53
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/exforge-hct-epar-all-authorised-presentations_en.pdf
document_name: exforge-hct-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 5.919151
conversion_datetime: 2025-12-19 00:21:31.714631
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.1-arm64-arm-64bit-Mach-O
---
| EU Number       | Invented name   | Strength             | Pharmaceutical Form   | Route of Administration   | Packaging          | Package size                        |
|-----------------|-----------------|----------------------|-----------------------|---------------------------|--------------------|-------------------------------------|
| EU/1/09/569/001 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/569/002 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/569/003 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/569/004 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/569/005 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/569/006 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/569/007 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |
| EU/1/09/569/008 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 x 1 tablet                       |
| EU/1/09/569/009 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 x 1 tablet                       |
| EU/1/09/569/010 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 tablet                      |
| EU/1/09/569/011 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 (4 x 70) tablet (multipack) |
| EU/1/09/569/012 | Exforge HCT     | 5 mg/160 mg/12.5 mg  | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 (20 x 14) tablets (multipack)   |
| EU/1/09/569/013 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/569/014 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/569/015 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/569/016 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/569/017 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/569/018 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/569/019 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |
| EU/1/09/569/020 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 x 1 tablet                       |
| EU/1/09/569/021 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 x 1 tablet                       |
| EU/1/09/569/022 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 tablet                      |
| EU/1/09/569/023 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 x 1 (4 x 70) tablet (multipack) |
| EU/1/09/569/024 | Exforge HCT     | 10 mg/160 mg/12.5 mg | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 (20 x 14) tablets (multipack)   |
| EU/1/09/569/025 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 14 tablets                          |
| EU/1/09/569/026 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 28 tablets                          |
| EU/1/09/569/027 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 30 tablets                          |
| EU/1/09/569/028 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 56 tablets                          |
| EU/1/09/569/029 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 90 tablets                          |
| EU/1/09/569/030 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 98 tablets                          |
| EU/1/09/569/031 | Exforge HCT     | 5 mg/160 mg/25 mg    | Film-coated tablet    | Oral use                  | blister (PVC/PVDC) | 280 tablets                         |

<div style=\"page-break-after: always\"></div>

| EU/1/09/569/032   | Exforge HCT   | 5 mg/160 mg/25 mg   | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 56 x 1 tablet                                        |
|-------------------|---------------|---------------------|----------------------|------------|----------------------|------------------------------------------------------|
| EU/1/09/569/033   | Exforge HCT   | 5 mg/160 mg/25 mg   | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 98 x 1 tablet                                        |
| EU/1/09/569/034   | Exforge HCT   | 5 mg/160 mg/25 mg   | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 tablet                                       |
| EU/1/09/569/035   | Exforge HCT   | 5 mg/160 mg/25 mg   | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 (4 x 70)                                     |
| EU/1/09/569/036   | Exforge HCT   | 5 mg/160 mg/25 mg   | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | tablet (multipack) 280 (20 x 14) tablets (multipack) |
| EU/1/09/569/037   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 14 tablets                                           |
| EU/1/09/569/038   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 28 tablets                                           |
| EU/1/09/569/039   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 30 tablets                                           |
| EU/1/09/569/040   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 56 tablets                                           |
| EU/1/09/569/041   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 90 tablets                                           |
| EU/1/09/569/042   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 98 tablets                                           |
| EU/1/09/569/043   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 tablets                                          |
| EU/1/09/569/044   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 56 x 1 tablet                                        |
| EU/1/09/569/045   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 98 x 1 tablet                                        |
| EU/1/09/569/046   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 tablet                                       |
| EU/1/09/569/047   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 (4 x 70) tablet (multipack)                  |
| EU/1/09/569/048   | Exforge HCT   | 10 mg/160 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 (20 x 14) tablets (multipack)                    |
| EU/1/09/569/049   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 14 tablets                                           |
| EU/1/09/569/050   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 28 tablets                                           |
| EU/1/09/569/051   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 30 tablets                                           |
| EU/1/09/569/052   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 56 tablets                                           |
| EU/1/09/569/053   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 90 tablets                                           |
| EU/1/09/569/054   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 98 tablets                                           |
| EU/1/09/569/055   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 tablets                                          |
| EU/1/09/569/056   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 56 x 1 tablet                                        |
| EU/1/09/569/057   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 98 x 1 tablet                                        |
| EU/1/09/569/058   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 tablet                                       |
| EU/1/09/569/059   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | 280 x 1 (4 x 70)                                     |
| EU/1/09/569/060   | Exforge HCT   | 10 mg/320 mg/25 mg  | Film-coated tablet   | Oral use   | blister (PVC/PVDC)   | tablet (multipack) 280 (20 x 14) tablets (multipack) |